Physicians' Academy for Cardiovascular Education

Latest insights from clinical trials

Slides (presentation) - Oct. 5, 2012

Latest insights from clinical trials:The unassailable case for LDL-c lowering

Selection of slides prepared & presented by:

Prof. Kausik Ray, MD
Professor of cardiovascular disease prevention, Honorary consultant cardiologist St George’s Hospital NHS Trust

at PACE Lipid Master Class
Budapest, September 21-2, 2012

View presentation, click on images

The overwhelming case for LDL-C lowering
4S Primary Endpoint: Total Mortality
HPS: Effects of Simvastatin
CTT Collaboration
Cholesterol Trialist Collaboration
Only high dose statins
All-Cause Death or Major CV Events in
Is there benefit from an LDL of
Cholesterol Trialist Collaboration
Meta-Analysis of Intensive Statin Therapy
Meta-Analysis of Intensive Statin Therapy
TNT: Incidence of First Major
Event rates by achieved LDL-C in trials
PROVE IT Safety Result
Adverse Event Profiles TNT
CTT Lancet 2012
Statins increase risk of Dysglycaemia
Statins and DYSGLYCAEMIA vs CVD Risk
New-Onset T2DM
Evidence for Clinical Benefit

The content is aimed for medical professionals. To view this item member registration is needed. Register for free to get unlimited access to our educational resources.

Share this page with your colleagues and friends: